Clinical Trials in Baltimore

Showing 10141-10160 of 23,476 trials

Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

NCT02323113

The purpose of the Phase 1b dose finding phase is to determine the safety, tolerability, and maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D) of TAK-659 in participants with relapsed or refractory AML. The purpose of the Phase 2 expansion phase is to evaluate preliminary efficacy of TAK-659 in relapsed or refractory AML as measured by overall response rate (ORR).

Acute Myelogenous Leukemia

Calithera Biosciences, Inc43 participantsStarted Mar 2015

Birmingham, Alabama, United States • Chicago, Illinois, United States • Niles, Illinois, United States +14 more locations

TERMINATEDNA< 1 mile

Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing

NCT02290119

The primary objectives of this study are to understand the effects of soft-tissue balancing on Gait, function and rehabilitation potential after sensor-assisted Total Knee Arthroplasty and correlate Intra-operative subjective feel with OrthoSensor Outputs Secondary objectives are to quantify and observe: * Pain medication use * Swelling * Muscle strength and girth * Gait efficiency * Patient satisfaction * Activity levels, functional return (i.e., back to work, resume normal activities) * Patient perception of a balanced knee

Osteoarthritis

Orthosensor, Inc.20 participantsStarted Apr 2018

Baltimore, Maryland, United States

Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)

Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing

Find Trials by Condition in Baltimore

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

ECG Belt for CRT Response

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Ultrasound for Scoliosis Diagnostic Evaluation

Cardiac Cath Lab Staff Radiation Exposure

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Sargramostim Use in COVID-19 to Recover Patient Health

SLSMDS Natural History Study

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis